6533b7dcfe1ef96bd12720d3
RESEARCH PRODUCT
Plasmonic Nanosensors for the Determination of Drug Effectiveness on Membrane Receptors.
Rubén Ahijado-guzmánChristina LambertzGermán RivasJanak PrasadJulia MentenCarsten Sönnichsensubject
0301 basic medicineDrugMaterials sciencemedia_common.quotation_subjectNanotechnologyCell Cycle Proteins02 engineering and technology03 medical and health sciencesBacterial ProteinsNanosensorEscherichia coliGeneral Materials ScienceSurface plasmon resonancePlasmonmedia_commonEscherichia coli ProteinsSurface Plasmon Resonance021001 nanoscience & nanotechnologyNanostructuresCytoskeletal Proteins030104 developmental biologyMembraneDrug developmentDrug deliveryFtsA0210 nano-technologyCarrier ProteinsProtein Bindingdescription
We demonstrate the potential of the NanoSPR (nanoscale surface plasmon resonance sensors) method as a simple and cheap tool for the quantitative study of membrane protein–protein interactions. We use NanoSPR to determine the effectiveness of two potential drug candidates that inhibit the protein complex formation between FtsA and ZipA at initial stages of bacterial division. As the NanoSPR method relies on individual gold nanorods as sensing elements, there is no need for fluorescent labels or organic cosolvents, and it provides intrinsically high statistics. NanoSPR could become a powerful tool in drug development, drug delivery, and membrane studies.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2016-12-22 | ACS applied materialsinterfaces |